Přihlásit se Zaregistrujte se zdarma

Návratnost jmění společnosti ProMIS Neurosciences

Jaká je hodnota metriky Návratnost jmění společnosti ProMIS Neurosciences?

Hodnota metriky Návratnost jmění společnosti ProMIS Neurosciences, Inc. je -364.81%

Jaká je definice metriky Návratnost jmění?



Návratnost kapitálu (Return on equity - ROE) je rentabilita vlastního kapitálu. Vypočítá se vydělením čistého příjmu za fiskální rok vlastním kapitálem.

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Návratnost jmění společností v sektoru Health Care sektor na OTC ve srovnání se společností ProMIS Neurosciences

Čemu se věnuje společnost ProMIS Neurosciences?

ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

Firmy s metrikou návratnost jmění podobnou společnosti ProMIS Neurosciences